Miao-fang Wu
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Determining the maximum tolerated dose of paclitaxel combined with fixed dose of cisplatin for hyperthermic intraperitoneal chemotherapy in ovarian cancer: A multicenter phase I trial.
Journal: Gynecologic oncology
Published: September 22, 2023
A phase I dose-finding trial of hyperthermic intraperitoneal docetaxel combined with cisplatin in patients with advanced-stage ovarian cancer.
Journal: Journal of gynecologic oncology
Published: February 09, 2023
Effects of neoadjuvant hyperthermic intraperitoneal chemotherapy on chemotherapy response score and recurrence in high-grade serous ovarian cancer patients with advanced disease: A multicentre retrospective cohort study.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: December 09, 2022
Association between subtypes of metabolic syndrome and prognosis in patients with stage I endometrioid adenocarcinoma: A retrospective cohort study.
Journal: Frontiers in oncology
Published: May 26, 2022
Efficacy of neoadjuvant hyperthermic intraperitoneal chemotherapy in advanced high-grade serous ovarian cancer (the NHIPEC trial): study protocol for a randomised controlled trial.
Journal: BMJ open
Published: December 17, 2021
Enhanced Efficacy of Neoadjuvant Chemotherapy with Nab-Paclitaxel and Platinum for Locally Advanced Cervical Cancer.
Journal: Cancer management and research
Published: October 09, 2021
Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients.
Journal: Journal of ovarian research
Published: November 30, 2020
A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy.
Journal: Frontiers in oncology
Published: October 11, 2020
The added value of CA125 normalization before interval debulking surgery to the chemotherapy response score for the prognostication of ovarian cancer patients receiving neoadjuvant chemotherapy for advanced disease.
Journal: Journal of Cancer
Published: September 01, 2020
Comparison of two types of the triple incision technique in the treatment of patients with locally advanced vulvar cancer.
Journal: International journal of medical sciences
Published: June 22, 2020
Identification of Ovarian Cancer Patients Most Likely to Achieve Chemotherapy Response Score 3 Following Neoadjuvant Chemotherapy: Development of a Predictive Nomogram.
Journal: Frontiers in oncology
Published: May 10, 2020
Feasibility and safety of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in patients with advanced stage ovarian cancer: a single-center experience.
Journal: Cancer management and research
Published: April 29, 2019
Last Updated: 09/26/2026